Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Aivista Quant Capital Launches Caelus AI and AQC Token Ecosystem, Ushering in a New Era of Intelligent Investing
-
ECD Automotive Design Granted Continued Listing by the Nasdaq Hearings Panel
-
24/7 Market News: Kraig Labs Targets Eco Luxury Spider Silk Apparel Market
-
AMN Healthcare Launches $400.0 Million Offering of Senior Notes
-
IMUNON Presents IMNN-001 Phase 2 Translational Data in Advanced Ovarian Cancer Demonstrating 13-Month OS Extension via Tumor Micro-Environment Shift
-
Blaze Pizza Ignites in Linden, New Jersey With Free Pizza Day Grand Opening Celebration on September 30
-
Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Gen
-
Lerøy Seafood Group ASA: Green Bond Mandate Announcement
-
Schouw & Co. share buy-back programme, week 38 2025
-
Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months
-
Announcement by Embraer S.A. of Offers to Purchase for Cash Certain Outstanding Securities Listed Below
-
Medtech Leader Erica Rogers Joins Ceribell Board of Directors
-
Lancaster Resources Secures District-Scale Expansion, Doubling Footprint at Lake Cargelligo Gold Project to 62,300 hectares
-
Aventis Energy Confirms Strong Radioactivity During Successful Exploration Program at the Corvo Uranium Project
-
LGI Homes Returns to Rio Rancho, NM, with the Grand Opening of Estrella at High Range
-
Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration
-
Connect Names Gretel von Son as Chief Operating Officer to Drive Growth in Entrepreneurship and Innovation
-
ORYZON to Sponsor First Phelan-McDermid Syndrome (PMS) Burden of Illness Study
-
Picard Advances Patent Protection for Fully Implantable Artificial Heart Technology
-
Cerevance to Present Phase 2 Data on Solengepras in Parkinson’s Disease at the 2025 International Congress of Parkinson's Disease and Movement Disorders
-
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Vuong Trieu, CEO of Oncotelic Therapeutics Inc.
-
Advent Technologies Delivers State-of-the-Art Portable Fuel Cell Systems under Contract with the U.S. Department of Defense
-
Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting
-
Idebenone Accepted by FDA for Priority Review for Leber Hereditary Optic Neuropathy (LHON)
-
Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
-
LifeVantage to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
-
Kratos Defense & Security Solutions to Join S&P MidCap 400 Index
-
electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards
-
Blue Sky Planners Launches a Gift-Worthy Collection with Morris & Co.
-
BioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart Failure
-
Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ESMO 2025
-
CEA Industries Board Authorizes $250 Million Stock Buyback Program
-
Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM
-
Terra Innovatum Advances U.S. NRC Licensing Process with Accelerated Regulatory Submissions for SOLO™ Reactor
-
Genius Group to host Genius Future Summit on October 2-3, 2025
-
Soup Capital Exchange Upgrades Trading Engine to Process Over 500,000 Orders per Second
-
SPWR to Acquire Sunder Energy to Gain U.S. No. 5 Spot
-
ProPhase Continues its Exploration of a Crypto Treasury Strategy
-
Voltus Ranked #1 Aggregator in GW Under Management and C&I Programs in Wood Mackenzie’s 2025 VPP Report
-
The Oncology Institute Achieves $1.1 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 2 through its California Professional Corporation
-
MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
-
Voltus Ranked #1 Aggregator in GW Under Management and C&I Programs in Wood Mackenzie’s 2025 VPP Report
-
Immutep Announces Research Collaboration with the George Washington University Cancer Center to Evaluate Neoadjuvant Efti
-
Synergy CHC (NASDAQ: SNYR) Taps Former Coca-Cola Executive to Lead Strategic Partnerships; Appoints Veteran Costco Buyer to Board of Directors
-
Slide Added to Russell 2000® Index
-
SemiCab Wins Prestigious Logistics Award, Industry Recognition for Best Value Award
-
UMH PROPERTIES, INC. ANNOUNCES INCREASED STOCK REPURCHASE AUTHORIZATION TO $100 MILLION
-
First-Ever EHR-Linked Devices Supercharge Timelier, Personalized Care
-
Kratos Defense & Security Solutions to Join S&P MidCap 400 Index
-
Secure Private Sale Partners with Wrench to Deliver Affordable, On-Demand Vehicle Maintenance to Drivers Nationwide via MobileMechanicNow.com
